JOANN IKARD: Open Payments
NPI 1669646329 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,694 in 26 payments from 10 companies in 2025. Trend: 2023 $2,748 · 2024 $2,698 · 2025 $1,694
Food & beverage: $1,685Education: $8
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $377 |
| UCB, Inc. | 3 | $343 |
| Janssen Biotech, Inc. | 3 | $255 |
| GENZYME CORPORATION | 8 | $145 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Galderma Laboratories, L.P. | 1 | $118 |
| PFIZER INC. | 2 | $116 |
| Amgen Inc. | 1 | $102 |
| Lilly USA, LLC | 1 | $92 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Rhapsido, COSENTYX, NEMLUVIO, LITFULO, EBGLYSS.
Industry payments across AL — which companies pay providers there.
